VEGF, VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients treated with thalidomide-based regimens

por Lopes-Aguiar, L, Delamain, M T, Brito, A B C, Lourenço, G J, Costa, E F D, Oliveira, G B, Vassallo, J, De Souza, C A, Lima, C S P
Publicado 2017

Association of VEGFA-2578 C>A polymorphism with clinicopathological aspects and outcome in follicular lymphoma patients

por de Mendonça, G R A, Brito, A B C, Rocha, R M, Delamain, M T, de Andrade Natal, R, Soares, F A, Colleoni, G W B, Souza, C A, Vassallo, J, Lima, C S P
Publicado 2016